SAGENT PHARMACEUTICALS, INC.
CIK 0001369786
Revenue (TTM)
—
Q2 Jul 2016
Net Income (TTM)
−$7.55M
+899.3% YoY
Q2 Jul 2016
EPS Diluted (TTM)
−$0.23
−1,000.0% YoY
Q2 Jul 2016
Gross Margin
—
Q2 Jul 2016
Operating Margin
—
Q2 Jul 2016
Net Margin
—
Q2 Jul 2016
Free Cash Flow (TTM)
−$43.54M
Q2 Jul 2016
Cash
$15.52M
Q2 Jul 2016
Total Debt
$5.98M
Q2 Jul 2016
Shares Outstanding
32.91M sh
Q2 Jul 2016
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.